Introduction
iCAN is a groundbreaking Finnish Research Flagship dedicated to solving the cancer challenge through cutting-edge discovery and innovation. The flagship is at the interface of precision cancer medicine and digital health, with the aim of advancing research and providing innovative solutions to tackle cancer.
iCAN News
Doctoral education pilot in precision cancer medicine launches in 2024
Finland’s Ministry of Education and Culture announced on 7.2.2024 the allocation of 255 million EUR to universities for piloting new practices…
Patient-researcher meeting in Tampere on 6.3.24 – on the topic of bowel cancer research
March is Bowel Cancer Awareness Month. To mark the occasion, iCAN, in collaboration with the Colorectal Cancer Association of Finland,…
iCAN science seminar on March 6 with Dr. Arafath (Rafa) Najumudeen
You are warmly welcome to iCAN science seminar on Wed 6.3.2024 at 13:30-14:30, Biomedicum, seminar room 1-2 or online. Speaker: Dr. Arafath (Rafa)…
iCAN in Numbers
iCAN Study Participants
Company collaborations
iCAN Publications
Invention
Disclosures
Patents
External Funding